WEBSITECHANGES

Website Changes

---

06/02/2013

Cyto-megalovirus might speed brain-cancer growth

---

06/01/2013

Overcoming cell size escape from tumor treating fields using a varying frequency treatment paradigm in vitro.

---

06/01/2013

Response assessment of novoTTF-100A versus best physician`s choice chemotherapy in recurrent glioblastoma.

---

06/01/2013

) Safety analysis of bevacizumab plus NovoTTF-100A in patients with recurrent malignant gliomas.

---

06/01/2013

Effect of tumor-treating fields on DNA repair in cancer cell lines.

---

06/01/2013

Meta-analysis of cancer cell lines genomes based on their response to ttfields.

---

06/01/2013

Genentech Announces Final Phase III Study Results of Avastin Plus Radiotherapy and Chemotherapy in People with an Aggressive Form of Brain Cancer

---

05/29/2013

Brain Tumor Awareness Day - Daily Living While Coping With A Brain Tumors

---

05/26/2013

Restoration of Sensitivity in Chemo - Resistant Glioma Cells by Cold Atmospheric Plasma. [Abstract]

---

05/26/2013

Cold plasma successful against brain cancer cells

---

05/26/2013

HAMLET: functional properties and therapeutic potential.

---

05/21/2013

Fundraisers: Mets and Twitter

---

05/21/2013

MGMT Promoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

---

05/18/2013

Defining pseudoprogression in glioblastoma multiforme.

---

05/18/2013

Isotretinoin maintenance therapy for glioblastoma: A retrospective review.

---

05/18/2013

Irinotecan delivery by microbubble-assisted ultrasound: in-vitro validation and a pilot preclinical study.

---

05/18/2013

av-Integrin isoform expression in primary human tumors and brain metastases.

---

05/14/2013

IBTA Newsletter

---

05/14/2013

Brainstorm Series Seminar on: REHABILITATION (In NJ)

---

05/14/2013

Ninth Surviving Brain Tumors Awareness Event, Thursday, May 16-Friday,Cleveland, Ohio

---

05/14/2013

Twitter Fundraiser

---

05/08/2013

Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner.

---

05/08/2013

ß1 Integrin Targeting Potentiates Antiangiogenic Therapy and Inhibits the Growth of Bevacizumab-Resistant Glioblastoma.

---

05/06/2013

Libertyville girl gets $7,000 haircut for charity

---

05/04/2013

Clinical trial participation and outcome for patients with glioblastoma: Multivariate analysis from a comprehensive dataset.

---